# Efficacy of Combination Therapy for Prevention of Effects of Malaria During Pregnancy

> **NCT00164255** · PHASE4 · COMPLETED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 1614 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** sulfadoxine/pyrimethamine
- **DRUG:** sulfadoxine/pyrimethamine plus artesunate

## Key facts

- **NCT ID:** NCT00164255
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 1614 (ACTUAL)
- **Last updated:** 2012-09-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00164255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00164255, "Efficacy of Combination Therapy for Prevention of Effects of Malaria During Pregnancy". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00164255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
